These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21226279)

  • 21. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.
    Freire de Carvalho J; Sherer Y; Shoenfeld Y
    Thromb Haemost; 2007 Dec; 98(6):1157-9. PubMed ID: 18064307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
    van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune-mediated mechanisms in atherosclerosis: prevention and treatment of clinical manifestations.
    Jirillo E
    Curr Pharm Des; 2007; 13(36):3648. PubMed ID: 18220801
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunomodulation of the inflammatory response in atherosclerosis.
    Kuiper J; van Puijvelde GH; van Wanrooij EJ; van Es T; Habets K; Hauer AD; van den Berkel TJ
    Curr Opin Lipidol; 2007 Oct; 18(5):521-6. PubMed ID: 17885422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.
    Spitz C; Winkels H; Bürger C; Weber C; Lutgens E; Hansson GK; Gerdes N
    Cell Mol Life Sci; 2016 Mar; 73(5):901-22. PubMed ID: 26518635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating atherosclerosis with regulatory T cells.
    Foks AC; Lichtman AH; Kuiper J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):280-7. PubMed ID: 25414253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells.
    Wigren M; Bengtsson D; Dunér P; Olofsson K; Björkbacka H; Bengtsson E; Fredrikson GN; Nilsson J
    Circ Res; 2009 Jun; 104(12):e62-70. PubMed ID: 19478203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis?
    Gerdes N; Zirlik A
    Thromb Haemost; 2011 Nov; 106(5):804-13. PubMed ID: 21979444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice.
    Kita T; Yamashita T; Sasaki N; Kasahara K; Sasaki Y; Yodoi K; Takeda M; Nakajima K; Hirata K
    Cardiovasc Res; 2014 Apr; 102(1):107-17. PubMed ID: 24403315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine network and T cell immunity in atherosclerosis.
    Ait-Oufella H; Taleb S; Mallat Z; Tedgui A
    Semin Immunopathol; 2009 Jun; 31(1):23-33. PubMed ID: 19340429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens.
    Nilsson J; Shah PK
    Atherosclerosis; 2021 Oct; 335():89-97. PubMed ID: 34462127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis.
    Little PJ; Chait A; Bobik A
    Pharmacol Ther; 2011 Sep; 131(3):255-68. PubMed ID: 21510977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T regulatory cells: a promising new target in atherosclerosis.
    Tselios K; Sarantopoulos A; Gkougkourelas I; Boura P
    Crit Rev Immunol; 2014; 34(5):389-97. PubMed ID: 25404046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunology of atherosclerosis.
    Gisterå A; Hansson GK
    Nat Rev Nephrol; 2017 Jun; 13(6):368-380. PubMed ID: 28392564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells in atherosclerosis: functions in immune regulation and beyond.
    Manthey HD; Zernecke A
    Thromb Haemost; 2011 Nov; 106(5):772-8. PubMed ID: 21901235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall.
    Ketelhuth DF; Hansson GK
    Thromb Haemost; 2011 Nov; 106(5):779-86. PubMed ID: 21979058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherosclerosis: immunopathogenesis and strategies for immunotherapy.
    Tabares-Guevara JH; Villa-Pulgarin JA; Hernandez JC
    Immunotherapy; 2021 Oct; 13(14):1231-1244. PubMed ID: 34382409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD3-specific antibodies: a portal to the treatment of autoimmunity.
    Chatenoud L; Bluestone JA
    Nat Rev Immunol; 2007 Aug; 7(8):622-32. PubMed ID: 17641665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.